ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

ACADIA Pharmaceuticals Ownership Summary


ACADIA Pharmaceuticals is owned by 97.68% institutional investors, 0.57% insiders, and 1.76% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.83% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.56% of its assets in ACADIA Pharmaceuticals shares.

ACAD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockACADIA Pharmaceuticals97.68%0.57%1.76%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp42.88M25.83%$786.81M
Vanguard group13.95M8.40%$255.94M
Blackrock funding, inc. /de12.73M7.67%$233.59M
Blackrock12.06M7.32%$196.01M
Rtw investments, lp8.71M5.25%$159.75M
State street4.52M2.72%$82.97M
D. e. shaw3.24M1.95%$59.48M
Goldman sachs group2.88M1.74%$52.86M
Geode capital management2.88M1.73%$52.81M
Palo alto investors lp2.75M1.66%$50.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp42.88M8.40%$786.81M
Palo alto investors lp2.75M7.82%$50.44M
Birchview capital, lp338.40K5.06%$6.21M
Cannon global investment management117.99K4.70%$2.17M
Stonepine capital management220.00K3.26%$4.04M
Rtw investments, lp8.71M2.42%$159.75M
Tang capital management1.50M1.82%$27.52M
Nan fung group102.98K1.62%$1.89M
Jgp global gestao de recursos ltda.34.62K1.45%$635.28M
Cm management70.00K1.15%$1.28M

Top Buyers

HolderShares% AssetsChange
Point72 asset management2.23M0.09%2.23M
Citigroup1.67M0.02%1.55M
Norges bank1.39M0.00%1.39M
Jacobs levy equity management1.36M0.09%1.36M
Goldman sachs group2.88M0.01%1.12M

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp8.71M2.42%-5.00M
State street4.52M0.00%-1.45M
Ecor1 capital---1.35M
Millennium management1.12M0.01%-934.76K
Finepoint capital lp---905.38K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.39M0.00%1.39M$25.55M
Great lakes advisors540.01K0.08%540.01K$9.91M
Burney co/378.90K0.25%378.90K$6.95M
Neo ivy capital management203.05K0.65%203.05K$3.30M
Cannon global investment management117.99K4.70%117.99K$2.17M

Sold Out

HolderChange
Concord wealth partners-10.00
Bokf, na-16.00
Capital performance advisors llp-25.00
Global retirement partners-40.00
Huntington national bank-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242949.70%162,117,2274.78%971.12%17134.65%74-7.50%
Sep 30, 2024266-3.97%154,699,805-3.89%930.99%127-15.89%801.27%
Jun 30, 2024275-4.51%160,951,1580.75%971.04%150-3.23%785.41%
Mar 31, 2024288-2.04%159,752,7730.26%961.02%155-4.32%741.37%
Dec 31, 202329411.36%159,346,4912.98%971.10%16223.66%73-1.35%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.61M4.56%4.76K
Vanguard Total Stock Mkt Idx Inv3.94M2.36%15.85K
Vanguard US Total Market Shares ETF3.89M2.33%4.42K
iShares Russell 2000 ETF3.15M1.89%-27.28K
Vanguard Small Cap Index3.12M1.87%-66.65K
SPDR® S&P Biotech ETF2.45M1.47%-26.30K
First Trust NYSE Arca Biotech ETF2.17M1.30%-
Vanguard Institutional Extnd Mkt Idx Tr1.91M1.15%49.18K
Vanguard Small Cap Growth Index Inv1.75M1.05%-34.36K
Fidelity Small Cap Index1.18M0.71%-22.14K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 08, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$40.13K
Apr 08, 2025Kihara James PRINCIPAL ACCOUNTING OFFICERSell$15.23K
Mar 26, 2025Kihara James PRINCIPAL ACCOUNTING OFFICERSell$18.67K
Mar 26, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$54.07K
Mar 05, 2025GAROFALO ELIZABETH A.-Sell$89.67K

Insider Transactions Trends


DateBuySell
2025 Q2-2
2025 Q1-5
2024 Q4-3
2024 Q3-3
2024 Q2-11

ACAD Ownership FAQ


Who Owns ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals shareholders are primarily institutional investors at 97.68%, followed by 0.57% insiders and 1.75% retail investors. The average institutional ownership in ACADIA Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which ACADIA Pharmaceuticals exceeds.

Who owns the most shares of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals’s largest shareholders are Baker bros. advisors lp (42.88M shares, 25.83%), Vanguard group (13.95M shares, 8.40%), and Blackrock funding, inc. /de (12.73M shares, 7.67%). Together, they hold 41.91% of ACADIA Pharmaceuticals’s total shares outstanding.

Does Blackrock own ACADIA Pharmaceuticals?

Yes, BlackRock owns 7.32% of ACADIA Pharmaceuticals, totaling 12.06M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 196.01M$. In the last quarter, BlackRock increased its holdings by 393.47K shares, a 3.37% change.

Who is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.40% of its assets in 42.88M ACADIA Pharmaceuticals shares, valued at 786.81M$.

Who is the top mutual fund holder of ACADIA Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ACADIA Pharmaceuticals shares, with 4.56% of its total shares outstanding invested in 7.61M ACADIA Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools